These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The use of monoclonal antibodies and related agents in the treatment of respiratory disease. Schachter EN; Neuman T Drugs Today (Barc); 2009 Jul; 45(7):533-48. PubMed ID: 19834630 [TBL] [Abstract][Full Text] [Related]
5. Personalized Medicine in Respiratory Disease: Role of Proteomics. Priyadharshini VS; Teran LM Adv Protein Chem Struct Biol; 2016; 102():115-46. PubMed ID: 26827604 [TBL] [Abstract][Full Text] [Related]
6. Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases. Chan Y; Raju Allam VSR; Paudel KR; Singh SK; Gulati M; Dhanasekaran M; Gupta PK; Jha NK; Devkota HP; Gupta G; Hansbro PM; Oliver BGG; Chellappan DK; Dua K Crit Rev Food Sci Nutr; 2023; 63(19):3302-3332. PubMed ID: 34613853 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives. Mayor A; Chesnay A; Desoubeaux G; Ternant D; Heuzé-Vourc'h N; Sécher T Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33668613 [TBL] [Abstract][Full Text] [Related]
8. TRP channels as therapeutic targets in airway disorders: a patent review. Preti D; Szallasi A; Patacchini R Expert Opin Ther Pat; 2012 Jun; 22(6):663-95. PubMed ID: 22667456 [TBL] [Abstract][Full Text] [Related]
9. Polyphenols as Therapeutics in Respiratory Diseases: Moving from Preclinical Evidence to Potential Clinical Applications. Emran TB; Eva TA; Zehravi M; Islam F; Khan J; Kareemulla S; Arjun UVNV; Balakrishnan A; Taru PP; Nainu F; Salim E; Rab SO; Nafady MH; Wilairatana P; Park MN; Kim B Int J Biol Sci; 2024; 20(8):3236-3256. PubMed ID: 38904027 [TBL] [Abstract][Full Text] [Related]
10. Safer approaches to therapeutic modulation of TGF-β signaling for respiratory disease. Lachapelle P; Li M; Douglass J; Stewart A Pharmacol Ther; 2018 Jul; 187():98-113. PubMed ID: 29462659 [TBL] [Abstract][Full Text] [Related]
11. Oligonucleotides: a multi-targeted approach for the treatment of respiratory diseases. Ferrari N; Seguin R; Renzi P Future Med Chem; 2011 Oct; 3(13):1647-62. PubMed ID: 21942254 [TBL] [Abstract][Full Text] [Related]
12. Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases. Liao W; Dong J; Peh HY; Tan LH; Lim KS; Li L; Wong WF Molecules; 2017 Jan; 22(1):. PubMed ID: 28106744 [TBL] [Abstract][Full Text] [Related]
13. Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases. Chellappan DK; Yee LW; Xuan KY; Kunalan K; Rou LC; Jean LS; Ying LY; Wie LX; Chellian J; Mehta M; Satija S; Singh SK; Gulati M; Dureja H; Da Silva MW; Tambuwala MM; Gupta G; Paudel KR; Wadhwa R; Hansbro PM; Dua K Drug Dev Res; 2020 Jun; 81(4):419-436. PubMed ID: 32048757 [TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease. Marwick JA; Chung KF; Adcock IM Ther Adv Respir Dis; 2010 Feb; 4(1):19-34. PubMed ID: 20051446 [TBL] [Abstract][Full Text] [Related]
15. Trends and Patterns of Differences in Chronic Respiratory Disease Mortality Among US Counties, 1980-2014. Dwyer-Lindgren L; Bertozzi-Villa A; Stubbs RW; Morozoff C; Shirude S; Naghavi M; Mokdad AH; Murray CJL JAMA; 2017 Sep; 318(12):1136-1149. PubMed ID: 28973621 [TBL] [Abstract][Full Text] [Related]
16. Role of iron in the pathogenesis of respiratory disease. Ali MK; Kim RY; Karim R; Mayall JR; Martin KL; Shahandeh A; Abbasian F; Starkey MR; Loustaud-Ratti V; Johnstone D; Milward EA; Hansbro PM; Horvat JC Int J Biochem Cell Biol; 2017 Jul; 88():181-195. PubMed ID: 28495571 [TBL] [Abstract][Full Text] [Related]
17. Predicting drug efficacy using integrative models for chronic respiratory diseases. Stevenson CS; Sridhar S; Phillips JE Inflamm Allergy Drug Targets; 2013 Apr; 12(2):124-31. PubMed ID: 23517645 [TBL] [Abstract][Full Text] [Related]
18. Multicity study of air pollution and mortality in Latin America (the ESCALA study). Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G; Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234 [TBL] [Abstract][Full Text] [Related]
19. Beneficial role of kaempferol and its derivatives from different plant sources on respiratory diseases in experimental models. Mishra S; Gandhi D; Tiwari RR; Rajasekaran S Inflammopharmacology; 2023 Oct; 31(5):2311-2336. PubMed ID: 37410224 [TBL] [Abstract][Full Text] [Related]
20. [Advance in the research on P2X7 and inflammatory respiratory diseases]. Cao SH; Yuan SP; Hou Q Yao Xue Xue Bao; 2013 Aug; 48(8):1183-8. PubMed ID: 24187823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]